An interventional study of Luminotherapy and /or Psychoeducation Program in Bipolar Disorder, sponsored by Centre Hospitalier Henri Laborit. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-13.
Sponsored by Centre Hospitalier Henri Laborit · Not applicable, Interventional, and Supportive care
Among 102 studies in Bipolar Disorder with a site in France — 34 open to participants now, 37 under way, 1 of them phase 3. Bipolar Disorder · France.
Among the 102 studies in Bipolar Disorder with a site in France, this one is the 39th largest by planned enrollment of the 77 interventional ones that give a count, is one of 7 that started in 2022, is one of 54 with no phase, reaches primary completion later than 15 of the 36 other live ones, and was the 67th registered.
1,683 studies on the registry are indexed under Bipolar Disorder; 266 are open to participants now.
This study's planned enrollment of 170 is above the median of 64 across 1,279 interventional studies indexed under Bipolar Disorder.
Browse Bipolar Disorder studies →34 of the 102 studies in Bipolar Disorder with a site in France are open now.
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 203 Bipolar Disorder studies recruiting now, 59 (29%) set no upper age limit and 132 (65%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →102 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 16 · Phase 4 2
First in 2004; this study’s year is marked. 7 started in 2022.
Median enrollment 170 across the 77 interventional studies, 100 across the 25 observational. Of the 45 that completed or were terminated, 12 (27%) have results posted.
25 of 102 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Henri Laborit is the lead sponsor of 27 studies on the registry; 17 are open to participants now.
Centre Hospitalier Henri Laborit has 1 study filed under Bipolar Disorder — fewer than ten, so there is no comparison to draw.
9 of the studies in Bipolar Disorder with a site in France that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07140913Phase 3Bristol-Myers SquibbA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine | 2027-06-28 |
| NCT07316803Centre hospitalier de Ville-Evrard, FranceGroup Intervention for Romantic Relationships in Young Adults With Severe Mental Illness | 2026-11-30 |
| NCT04917419Centre Hospitalier Henri LaboritNursing Care of Bipolar Patients With Sleeping Disorders Using Luminotherapy and /or Psychoeducation Program (BIPLUMINO) | 2026-12 |
| NCT05878730Assistance Publique - Hôpitaux de ParisMelatonin and Response to Lithium | 2026-12 |
| NCT06059313Nantes University HospitalPremorbid Personality Profile of Patients With Cognitive and Behavioral Disorders | 2026-12-14 |
Among the 102 studies in Bipolar Disorder with a site in France, from their registry updates:
Bipolar disorder affects more than 1% of the population. This pathology is considered as one of the most serious psychiatric disorder because of it is high suicide rates. It impacts patients life quality on many aspects, and specially their sleeping and circadian Rhythms. This can lead to more severe symptoms up to for thymic relapses. It was shown that Luminotherapy and Psychoeducation Program have a positive impact on these type of symptoms.
Main inclusion Criteria:
Main exclusion Criteria:
Other: Luminotherapy and /or Psychoeducation Program
Other: Luminotherapy and /or Psychoeducation Program
TO complete
Number of days in-hospital
Number of days patients spent in the hospital
Time frame: Day 0 to Day 365
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2022 (actual). Primary completion is estimated for Dec 2026, 48 months after the start.
Of 352 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 48 months is above that.
Counting every sponsor, half of 354 studies reached it within 37 months; a quarter within 23 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Henri Laborit